Deutsche Bank’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $427K | Buy |
|
|||||
|
2025
Q2 | $479K | Sell |
|
|||||
|
2025
Q1 | $309K | Sell |
|
|||||
|
2024
Q4 | $344K | Buy |
|
|||||
|
2024
Q3 | $146K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $78K | Sell |
|
|||||
|
2021
Q4 | $270K | Buy |
|
|||||
|
2021
Q3 | $332K | Buy |
|
|||||
|
2021
Q2 | $416K | Sell |
|
|||||
|
2021
Q1 | $377K | Sell |
|
|||||
|
2020
Q4 | $336K | Sell |
|
|||||
|
2020
Q3 | $1.11M | Buy |
|
|||||
|
2020
Q2 | $3.75M | Buy |
|
|||||
|
2020
Q1 | $1.8M | Buy |
|
|||||
|
2019
Q4 | $504K | Buy |
|
|||||
|
2019
Q3 | $180K | Sell |
|
|||||
|
2019
Q2 | $723K | Buy |
|
|||||
|
2019
Q1 | $797K | Sell |
|
|||||
|
2018
Q4 | $958K | Sell |
|
|||||
|
2018
Q3 | $3.17M | Buy |
|
|||||
|
2018
Q2 | $1.62M | Sell |
|
|||||
|
2018
Q1 | $4.4M | Buy |
|
|||||
|
2017
Q4 | $2.4M | Sell |
|
|||||
|
2017
Q3 | $4.16M | Sell |
|
|||||
|
2017
Q2 | $3.95M | Buy |
|
|||||
|
2017
Q1 | $193K | Sell |
|
|||||
|
2016
Q4 | $254K | Buy |
|
|||||
|
2016
Q3 | $125K | Sell |
|
|||||
|
2016
Q2 | $202K | Buy |
|
|||||
|
2016
Q1 | $172K | Sell |
|
|||||
|
2015
Q4 | $260K | Buy |
|
|||||
|
2015
Q3 | $156K | Sell |
|
|||||
|
2015
Q2 | $1.76M | Buy |
|
|||||
|
2015
Q1 | $49K | Sell |
|
|||||
|
2014
Q4 | $115K | Buy |
|
|||||
|
2014
Q3 | $1K | Buy |
|
|||||
|
2014
Q2 | $1K | Buy |
|